je.st
news
Higher risk of surgery seen with Bayer Essure contraceptive: study
2015-10-15 00:20:08| Biotech - Topix.net
REUTERS: Women implanted with Bayer AG's Essure permanent contraception device were more than 10 times more likely to require post-procedure surgery than those who underwent laparoscopic sterilization, a study published on Tuesday found. The findings could cast additional doubt on the safety of the Bayer device, which was approved in 2002 as an alternative to surgical sterilization and acquired by Bayer in 2013.
Tags: study
higher
risk
surgery
Category:Biotechnology and Pharmaceuticals